These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11597316)

  • 1. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.
    Berx G; Van Roy F
    Breast Cancer Res; 2001; 3(5):289-93. PubMed ID: 11597316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas.
    Berx G; Nollet F; van Roy F
    Cell Adhes Commun; 1998; 6(2-3):171-84. PubMed ID: 9823469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor.
    Shargh SA; Sakizli M; Khalaj V; Movafagh A; Yazdi H; Hagigatjou E; Sayad A; Mansouri N; Mortazavi-Tabatabaei SA; Khorram Khorshid HR
    Med Oncol; 2014 Nov; 31(11):250. PubMed ID: 25260805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.
    Borcherding N; Cole K; Kluz P; Jorgensen M; Kolb R; Bellizzi A; Zhang W
    Am J Pathol; 2018 Aug; 188(8):1910-1920. PubMed ID: 29879416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
    Karch I; Schipper E; Christgen H; Kreipe H; Lehmann U; Christgen M
    PLoS One; 2013; 8(8):e73062. PubMed ID: 24023670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements.
    Christgen M; Bartels S; van Luttikhuizen JL; Bublitz J; Rieger LU; Christgen H; Stark H; Sander B; Lehmann U; Steinemann D; Derksen PWB; Kreipe H
    Mod Pathol; 2020 Dec; 33(12):2483-2498. PubMed ID: 32572153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance.
    Asgeirsson KS; Jónasson JG; Tryggvadóttir L; Olafsdóttir K; Sigurgeirsdóttir JR; Ingvarsson S; Ogmundsdóttir HM
    Eur J Cancer; 2000 Jun; 36(9):1098-106. PubMed ID: 10854942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
    Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
    Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
    Berx G; Cleton-Jansen AM; Nollet F; de Leeuw WJ; van de Vijver M; Cornelisse C; van Roy F
    EMBO J; 1995 Dec; 14(24):6107-15. PubMed ID: 8557030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
    Berx G; Cleton-Jansen AM; Strumane K; de Leeuw WJ; Nollet F; van Roy F; Cornelisse C
    Oncogene; 1996 Nov; 13(9):1919-25. PubMed ID: 8934538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
    Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
    Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study.
    Rakha EA; Teoh TK; Lee AH; Nolan CC; Ellis IO; Green AR
    Histopathology; 2013 Apr; 62(5):695-701. PubMed ID: 23347178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.